Regulatory perspective

被引:0
|
作者
Anon
机构
来源
Water Environment and Technology | 2002年 / 14卷 / 04期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [21] Corruption from a Regulatory Perspective
    Villoria, Manuel
    PUBLIC INTEGRITY, 2023, 25 (05) : 530 - 533
  • [22] Rosiglitazone: a European regulatory perspective
    E. Blind
    K. Dunder
    P. A. de Graeff
    E. Abadie
    Diabetologia, 2011, 54 : 213 - 218
  • [23] ALARA in practice: A regulatory perspective
    Godas, T
    Malmqvist, LA
    IRPA9 - 1996 INTERNATIONAL CONGRESS ON RADIATION PROTECTION / NINTH INTERNATIONAL CONGRESS OF THE INTERNATIONAL RADIATION PROTECTION ASSOCIATION, PROCEEDINGS, VOL 1, 1996, : A303 - A310
  • [24] FAT SUBSTITUTES - A REGULATORY PERSPECTIVE
    VANDERVEEN, JE
    GLINSMANN, WH
    ANNUAL REVIEW OF NUTRITION, 1992, 12 : 473 - 487
  • [25] The Regulatory Imperative: International Perspective
    Bertram, Tim
    Hellman, Kiki B.
    Bayon, Yves
    Ellison, Simon
    Wilburn, Sarah
    TISSUE ENGINEERING PART B-REVIEWS, 2013, 19 (03) : 191 - 193
  • [26] A Regulatory Perspective on Biosimilar Medicines
    Cordeiro, Marta Agostinho
    Vitorino, Carla
    Sinogas, Carlos
    Sousa, Joao J.
    PHARMACEUTICS, 2024, 16 (03)
  • [27] PESTICIDES FROM A REGULATORY PERSPECTIVE
    CRAWFORD, LM
    SCHOR, DM
    ACS SYMPOSIUM SERIES, 1991, 446 : 308 - 312
  • [28] REGULATORY IMPLICATIONS - AN AUTHORITY PERSPECTIVE
    CARTWRIGHT, AC
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) : 465 - 467
  • [29] The safety of kava - a regulatory perspective
    Richardson, W. N.
    Henderson, L.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (04) : 418 - 420
  • [30] Population PharmacokineticsA Regulatory Perspective
    He Sun
    Emmanuel O. Fadiran
    Carolyn D. Jones
    Lawrence Lesko
    Shiew-Mei Huang
    Karen Higgins
    Chuanpu Hu
    Stella Machado
    Samuel Maldonado
    Roger Williams
    Mohammad Hossain
    Ene I. Ette
    Clinical Pharmacokinetics, 1999, 37 : 41 - 58